Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 36,076	$ 41,786
Prepaid expenses and other current assets	4,223	3,734
Total Current Assets	40,299	45,520
Non-Current Assets
Property and equipment, net	324	345
Restricted cash	100	99
Right of use asset	2,054	1,199
In-process research and development	19,469	19,150
Goodwill	5,617	5,525
Deposits and other assets	23	23
Total Assets	67,886	71,861
Current Liabilities:
Accounts payable	480	915
Accrued expenses	2,076	1,496
Accrued employee benefits	649	1,403
Contingent consideration, current portion	4,911	2,973
Loans payable-current	66	57
Operating lease liability	437	216
Total Current Liabilities	8,619	7,060
Non-current Liabilities
Non-current contingent consideration	5,408	7,211
Loan Payable - Long term	160	221
Deferred tax liabilities, net	1,311	1,618
Lease liability - Long term	1,802	1,187
Total Liabilities	17,300	17,297
Commitments and Contingencies
Stockholders' Equity:
Common stock, $0.001 par value; 350,000,000 shares authorized, 15,844,294 issued and 15,124,061 outstanding at March 31, 2023 and 15,844,294 issued and 15,124,061 outstanding at December 31, 2022	16	16
Additional paid-in capital	343,876	343,750
Treasury stock at cost, 720,233 shares at March 31, 2023 and at December 31, 2022	(288)	(288)
Accumulated other comprehensive loss	(305)	(679)
Accumulated deficit	(295,447)	(290,969)
Total Stockholders' Equity	47,852	51,830
Total Liabilities and Stockholders' Equity	67,886	71,861
Series C convertible preferred stock
Temporary Equity
Convertible preferred stock	2,006	2,006
Series D convertible preferred stock
Temporary Equity
Convertible preferred stock	$ 728	$ 728